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MIDLIFE WOMEN MAINTAINING ENRICHING RECOVERY FROM ALCOHOL
DEPENDENCE
J.B. Withnall, S.B. Hill, S.R. Bourgeois
University of Western Sydney, New South Wales, Australia
This transdisciplinary qualitative action research was initiated to explore why the number of
midlife women diagnosed alcohol dependent in Australia had risen from 8% in 1996 to 16% in
2005, with most being non-disadvantaged women, and to propose holistic and gender-
sensitive ways for addressing this and preventing further increase.
MethodTwo groups of participants were recruited using the Australian media: 25 to 60 year
old women who have been alcohol dependent but abstinent for more than two years, and
healthcare professionals caring for such women. The research was collaborative using a
comprehensive social ecology framework (Hill 1996). Mixed methods and technologies (eg
NVivo 7,OriginLab 7.5 software) were used for data collection and analysis, which was guided
by participants’ cross checking, critical reflection, and provision of ‘‘care with compassion’’
(Bourgeois 2005). Results were compared with the findings of two current Australian studies
on womens’ health and mental health.
Findings highlight the need for a greater emphasis on recovery over harm minimisation
policies and services, and on the need to transform Australia’s ‘‘cultural acceptance of
intoxication.’’ Most medical and health professionals were significantly unaware of the rapid
increase among women of alcohol misuse, and associated abuse and its complex mental and
physical effects. Few were up-to-date with the current understanding of alcoholism as a brain
disorder and with the interrelationships between genetic and environmental risk factors and
predispositions. There was also little understanding of the particular barriers for midlife
women seeking access to effective health treatments and support such as the stigma and
discriminatory attitudes towards ‘‘female drunks, especially mothers.’’
An ‘‘ecology of recovery’’ (living systems) and transformative learning approach to recovery
was designed to address women’s needs and improve professional practice. This
neuropsychosocial approach emphasised provision of a safe, nurturing place with time to
focus on the women’s self engagement, embodiment and enrichment (Withnall 2006), and
therapeutic and peer support to enable them to build resilience and progress towards self-
managed long-term recovery. This approach, our improved model of midlife recovery and
proposed mental health praxis theory of ‘‘integrative change’’ can support women’s transition
through this chaotic chronic illness to fulfilling wellbeing.
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TOBACCO USE AND NICOTINE DEPENDENCE IN A TREATMENT-BASED SAMPLE OF
PREGNANT DRUG DEPENDENT WOMEN WITH AND WITHOUT COMORBID PRENATAL
ALCOHOL USE
J.N. Gray, D.S. Svikis, N. Haug
Virginia Commonwealth University, Richmond, VA 23220, USA
The majority of pregnant illicit drug dependent women also use or abuse legal substances
such as alcohol and tobacco. Both of these substances are associated with a variety of
adverse maternal and infant outcomes (e.g., low birthweight, mental retardation, prematurity),
yet they are often overlooked by treatment providers who focus instead on the cocaine and/or
opiate dependence. The present study examined smoking characteristics and severity of
nicotine dependence in a sample of cocaine and opiate dependent pregnant women with and
without co-morbid alcohol problems. Participants were 109 pregnant drug dependent women
admitted to residential treatment. All provided consent as part of a larger behavioral research
study and completed the Addiction Severity Index (ASI) and Fagerstrom Test for Nicotine
Dependence (FTND) as part of baseline assessment. Participants had an average age of
29.1 years (SD = 4.4 years) and 87% were African American. Women were categorized as
alcohol positive (Alc+) if they reported any alcohol use in past 30 days and alcohol negative
(Alc-) if no recent (past 30 days) drinking was reported. Nearly all women reported recent
tobacco use (97% daily use past 30 days). While Alc+ and Alc- women reported smoking
similar numbers of cigarettes per day (Mean = 17 cigs/day, SEM 1.0), a positive correlation
was found between number of drinks consumed per day and number of cigarettes smoked
per day in the month prior to treatment enrollment (r=0.4). Interestingly, however, Alc- women
obtained higher mean FTND scores than Alc+ women (4.5 (SEM 0.2) and 3.5 (SEM 0.4),
respectively) (p<.05). Study findings confirm high rates of comorbid alcohol and tobacco use
in pregnant drug dependent women. Results also suggest alcohol and tobacco use are
related to one another and that treatment providers should address use of both substances
during treatment planning as prenatal alcohol and tobacco consumption are associated with
negative maternal and infant outcomes.
This research was supported by R01 grant from NIAAA and a Center grant from NIDA.
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NALTREXONE DECREASES ALCOHOL DRINKING LEVELS IN SMOKING CESSATION
A.C. King, C. Vanier, D. Cao, & T. Wilcox
University of Chicago, Chicago, IL 60637
There is some support for the efficacy of the opioid antagonist naltrexone in the treatment of
nicotine dependence. One potential unexplored mechanism underlying naltrexone’s effects in
smoking cessation may be in its ability to reduce alcohol consumption, as alcohol can be a
potent trigger for smoking relapse. Alcohol consumption (weekly drinking levels and binge
drinking rates) and liver enzyme levels (AST, ALT) were examined in a sample of 78
nonalcoholic social drinking smokers (34 naltrexone, 44 placebo) enrolled in a double-blind
randomized clinical trial of naltrexone in smoking cessation. Naltrexone (50 mg) or placebo
began three days prior to the quit date (25 mg daily) and continued for eight weeks (50 mg
daily). All participants received nicotine patch and behavioral counseling up through four
weeks after the quit date. Baseline drinks per week was similar between the naltrexone and
placebo groups [M (SEM) = 7.6 (0.9) drinks weekly]. Naltrexone significantly decreased
weekly alcohol drinking during the first two weeks after the quit date compared with placebo
[4.2 (1.0) versus 6.5 (1.2) drinks weekly, respectively; week x group: beta (se) = 0.266
(0.127), p <.05], but this difference was no longer evident during the ensuing six weeks of
treatment. Within the subgroup of regular binge drinkers (N=36; 15 naltrexone, 21 placebo),
naltrexone but not placebo significantly decreased binge drinking rates over the majority of
the weekly intervals during the eight weeks of treatment [week x group: beta (se) = 1.259
(0.254), p <.001]. Further, smoking cessation outcomes were better in binge drinker on
naltrexone vs. placebo (80% vs. 52% quit after one month; X^2 = 2.89, p=0.09). AST and
ALT levels were similar at baseline and there was no statistically significant difference in
elevations of AST or ALT between the placebo and naltrexone group. In sum, naltrexone
appears to increase smoking quit rates and reduce alcohol drinking levels, particularly in
heavier social drinkers and during the early stages of smoking cessation treatment. These
data were supported by a biomarker of drinking outcomes and indicated that naltrexone at 50
mg daily does not cause significant liver inflammation in smokers.
Supported by K08-AA00276, R01-DA016834, M01-R00055, and P30-CA14599.
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INPATIENTS WITH UNHEALTHY ALCOHOL USE: DRINKING AND ALCOHOL
CONSEQUENCES AT 12 MONTHS
N. Bertholet, D.M. Cheng, T. Palfai, R. Saitz
Boston University, Boston, MA
Background: In medical hospitals, most patients drinking at-risk amounts meet criteria for
alcohol dependence. But the natural history of unhealthy alcohol use and predictors of
favorable outcome have not been well characterized.
Method: Medical inpatients drinking at-risk amounts were assessed at baseline and 12
months later on consumption (30-day TimeLine Follow-Back) and alcohol related
consequences (Short Inventory of Problems). Physical health-related quality-of-life was
assessed with the Short-Form Health Survey (PCS score), depressive symptoms with the
Center for Epidemiologic Studies Depression scale (CESD) and commitment to change with
the Taking Action scale derived from the SOCRATES. For each subject, drinking was
categorized as either favorable (defined as abstinence or drinking ‘‘moderate’’ amounts [i.e.
less than at-risk amounts] without consequences) or unfavorable (drinking moderate amounts
with consequences or drinking at-risk amounts [>14 drinks/wk or >=5/occasion for men, >7/wk
or >=4/occ. for women and persons aged >=66]). Logistic regression adjusting for age,
gender, race/ethnicity, PCS score and drinks/day at baseline was used to evaluate predictors
of a favorable outcome.
Results: Of the 341 subjects, 84% had complete data at 12 months. They drank a mean (SD)
6.8 (8.9) drinks/day, 70% were men, 78% had alcohol dependence. At 12 months, 33% had a
favorable outcome. In the adjusted logistic regression model, no time with heavy drinking
friends (i.e. social pressure to drink)(Adjusted Odds Ratio [AOR] 2.28, 95%CI 1.23-4.25),
receipt of alcohol assistance in the past year (in-/outpatient specialty treatment, counseling,
AA or other self-help groups, pharmacotherapy)(AOR 2.11, 95%CI 1.18-3.76), and
commitment to change at study entry (AOR 1.11 per 1 point increase in Taking Action (range
6-30), 95%CI 1.05-1.17) were associated with a favorable outcome. Education,
homelessness, past physical or sexual abuse, heroin or cocaine use, marijuana use,
depression, and presence of alcohol dependence at baseline were not significantly associated
with outcome (all p>0.1).
Conclusion: Although most inpatients with unhealthy alcohol use continue to drink at-risk
amounts and/or have consequences, one third are either abstinent or drink moderate
amounts without consequences 1 year later. Less social pressure to drink, receipt of alcohol
assistance, and commitment to change drinking are positively associated with this favorable
outcome.
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